Clinical Trials Logo

Indolent B-cell NHL clinical trials

View clinical trials related to Indolent B-cell NHL.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01289223 Terminated - Indolent B-cell NHL Clinical Trials

A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.

ROBIN
Start date: February 2011
Phase: Phase 3
Study type: Interventional

To compare the efficacy of bendamustine against treatment of physician's choice on progression-free survival in subjects with indolent B-cell NHL.